Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Fowler

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
American Heart Journal|December 22, 2005
Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS studyHenry Krum, Paul Mohacsi, Hugo A Katus, et al.
JAMA|February 15, 2003
Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS StudyHenry Krum, Ellen B Roecker, Paul Mohacsi, et al.
JACC. Heart Failure|October 14, 2019
A Changing Landscape of Mortality for Systemic Light Chain AmyloidosisChristopher D Barrett, Katharine Dobos, Michaela Liedtke, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 3, 2007
Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registryWilliam T Abraham, Barry M Massie, Mary Ann Lukas, et al.
The American Journal of Cardiology|May 5, 2007
Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practiceBarry M Massie, Jeanenne J Nelson, Mary Ann Lukas, et al.
American Heart Journal|June 2, 2007
Beta-blocker dosing in community-based treatment of heart failureMichael B Fowler, Sandra R Lottes, Jeanenne J Nelson, et al.
Congestive Heart Failure (Greenwich, Conn.)|December 16, 2006
Heart failure in community practice: relationship to age and sex in a beta-blocker registryJoseph A Franciosa, Jeanenne J Nelson, Mary Ann Lukas, et al.
The American Journal of Cardiology|November 28, 2006
Predictors of clinical outcomes in patients given carvedilol for heart failureBarry Greenberg, Sandra R Lottes, Jeanenne J Nelson, et al.
Journal of the American College of Cardiology|April 20, 2004
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) studyJean L Rouleau, Ellen B Roecker, Michal Tendera, et al.
European Journal of Heart Failure|February 28, 2004
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudyFranz Hartmann, Milton Packer, Andrew J S Coats, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
American Heart Journal|December 22, 2005
Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS studyHenry Krum, Paul Mohacsi, Hugo A Katus, et al.
JAMA|February 15, 2003
Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS StudyHenry Krum, Ellen B Roecker, Paul Mohacsi, et al.
JACC. Heart Failure|October 14, 2019
A Changing Landscape of Mortality for Systemic Light Chain AmyloidosisChristopher D Barrett, Katharine Dobos, Michaela Liedtke, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 3, 2007
Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registryWilliam T Abraham, Barry M Massie, Mary Ann Lukas, et al.
The American Journal of Cardiology|May 5, 2007
Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practiceBarry M Massie, Jeanenne J Nelson, Mary Ann Lukas, et al.
American Heart Journal|June 2, 2007
Beta-blocker dosing in community-based treatment of heart failureMichael B Fowler, Sandra R Lottes, Jeanenne J Nelson, et al.
Congestive Heart Failure (Greenwich, Conn.)|December 16, 2006
Heart failure in community practice: relationship to age and sex in a beta-blocker registryJoseph A Franciosa, Jeanenne J Nelson, Mary Ann Lukas, et al.
The American Journal of Cardiology|November 28, 2006
Predictors of clinical outcomes in patients given carvedilol for heart failureBarry Greenberg, Sandra R Lottes, Jeanenne J Nelson, et al.
Journal of the American College of Cardiology|April 20, 2004
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) studyJean L Rouleau, Ellen B Roecker, Michal Tendera, et al.
European Journal of Heart Failure|February 28, 2004
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudyFranz Hartmann, Milton Packer, Andrew J S Coats, et al.
Pageof 4